BIONOR IMMUNO AS

Signals

4 flags

• ⚠ Konkurs Selskapet er registrert konkurs i Enhetsregisteret.
• ▼ Negativ egenkapital 2024 Bokført egenkapital er negativ (−17,1 mill kr).
• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−93k kr).
• ◆ Nylig endring 2026-07-18 Konkurs registrert 2026-07-18.

BIONOR IMMUNO AS is registered as a limited company in Oslo, Oslo with organisation number 982248108. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2000. Registered share capital is NOK 984,000, divided into 89434931 shares. The company's stated purpose is: “Handel, rådgivning, produksjon, bioteknologisk forskning, utvikling og kommersialsiering, eie og forvalte aksjer og andre verdipapirer, delta i andre foretak og alt som har forbindelse med dette.”.

Key figures · 2024

Operating profit

NOK −93,000

Equity

NOK −17.1m

Financial health · 2024

Liquidity

0.01

Not satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-12415.0%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns BIONOR IMMUNO AS?

BIONOR HOLDING AS

100.0%

BIONOR IMMUNO AS

· NOK −93,000 profit

BIONOR IMMUNO AS has 1 registered shareholder:

• BIONOR HOLDING AS 100.0%

All shareholders and roles →

Frequently asked questions about BIONOR IMMUNO AS

Who owns BIONOR IMMUNO AS?

BIONOR HOLDING AS is the largest registered owner, with 100.0%.

Who is the general manager of BIONOR IMMUNO AS?

Birger Sørensen is registered as general manager of BIONOR IMMUNO AS.

Where is BIONOR IMMUNO AS based?

BIONOR IMMUNO AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.